What’s Mampilly’s “1 Pot Company” with revenue “expected to surge 3,988%?”

Some Monday Morning Marijuana Guessing

By Travis Johnson, Stock Gumshoe, February 11, 2019

Paul Mampilly’s huge marketing machine at Banyan Hill tends to drive a lot of questions our way, and this latest one about a medical marijuana stock caught my eye… but I should warn you up front that it’s a teaser ad that’s very light on clues… today we’re going to have to do some guessing.

So what’s the story? Well, Mampilly’s promoting his $10 Million Portfolio ($4,995 one time fee, no refunds, plus $499/year for ongoing access), which is the hole of the marketing funnel and, if Banyan Hill is like other publishers, by far the most profitable one.

This service is promoted as using Mampilly’s “GAP Strategy”, which he describes using an acronym:

“G stands for ground floor.
“A stands for accelerated profits.
“And P stands for peak pessimism.”

From the examples he gives, most of which were either highly levered investments made during the financial crisis (like Paulson’s bet against mortgages, or Berkshire’s “rescue” investment in Bank of America) or picks of companies that were on the verge of bankruptcy, it seems to basically mean, “buy hated stuff.”

Which is certainly a time-tested strategy, if you can buy what other people don’t want to buy you’ve improved your odds of “winning.” You haven’t made the odds of success 100%, not even close (there’s usually a really good reason why no one else wants to buy those stocks, of course), but you’ve increased the chances that you’re buying at a good price.

So what is it that we’re being teased with today? Last time out, Mampilly was teasing Fannie Mae (FNMA), which certainly fits the “beaten down” stock that no one else loves, and it so happened that he had great timing — his pitch came out just after the market bottomed, and just as the chatter about another attempt at re-capitalizing or reforming the federal home loan guarantors heated up again, so the stock just about doubled in the past month.

This time… well, I’m not going to be as definitive as I was in answering that teaser question on January 4, but I’ll check out the few clues and give you a guess or two.

Here’s how the stock is hinted at in Mampilly’s ad:

“I am moments away from releasing a brand-new trade recommendation for my elite The $10 Million Portfolio readers….

Are you getting our free Daily Update
"reveal" emails? If not,
just click here...


“… this stock sits at ground zero in one of the most explosive markets I’ve seen in decades β€” medical marijuana….”

And he gets more specific about the timing of his upcoming recommendation in some versions of the ad:

“This Wednesday, I will be issuing a critical trade recommendation for members of The $10 Million Portfolio research service.

“In fact, it may be one of the most important picks I’ve made … at any time.”

(In case you’re wondering, I first started receiving this ad on Friday afternoon, February 8… so presumably that means he’ll be releasing this lightly-teased idea to his subscribers in a couple days, on Wednesday, February 13.)

Anything specific that the Thinkolator can chew on? We do get this:

“You see, this ‘off-the-radar’ pot stock company expects its revenues to soar from $15 million in 2018 to $601 million in 2020.”

That’s a huge number, by the way. Even giant Canopy Growth (CGC), long the highest-profile of the Canadian marijuana companies, is only expected to have about $600 million in revenue in 2020 ($618 million is the average estimate by analysts).

(No, he’s not teasing Canopy Growth — CGC had more than $70 million in revenue in 2018).

So… which stock could this be?

There are a number of possibilities…

Curaleaf Holdings (CURA.CX, CURLF) — this US cultivation and dispensary rollup had about $16 million in revenue in the third quarter last year, and no revenue in the prior quarters, so you could stretch that to be a match… and there are two analysts giving 2020 revenue guesses for this one, averaging out to $595 million. Not particularly at a “pessimistic” price at the moment, it did dip a bit after they went public at the end of October at a crazy valuation but it is now back to very close to that C$11 initial share price. Curaleaf focuses on “medical and wellness” and the investment case is similar to a few others like MedMen who are trying to build out big multi-state networks to take advantage of advancing (but not too fast) US legalization (as long as marijuana remains a schedule 1 drug in the US, interstate transport remains illegal — and a lot of states require that cultivation, processing and retail all be handled within the state).

Harvest Health & Recreation (HARV.CX, HTHHF) didn’t have any revenue to speak of in the first three quarters of last year, but is forecast (by one or two analysts, at least) to have $15.8 million in the fourth quarter… with an average forecast of $548 million for 2020 revenue. This one is nowhere near “peak pessimism,” though, it started trading a few months ago and is at all-time highs right now.

WeedMD (WMD.V, WDDMF), which is seeking to differentiate itself in part with medical products, including CBD and THC oils for the senior care segment, and which says it has a catalogue of seeds and plants that are being used by other producers. I don’t see any real forecast of $600 million in 2020 revenue by the company or anyone else, and the stock is not particularly beaten down at the moment, but it is a current revenue match, to some extent, with C$14.5 million in revenue over the past four quarters.

And The Green Organic Dutchman (TGOD.TO, TGODF) is a pretty good match on the numbers as well, they have just started posting revenue and are forecast to have $14.7 million in revenue for 2018 and $600 million in 2020… and while they are not entirely medical (they are positioning themselves as an organic grower, for the most part, with facilities in Quebec and Ontario), they are pushing the angle that medical marijuana customers value organic products (and, of course, that organic marijuana trades at a premium to the regular stuff). And they are somewhat beaten down, the stock has been weak for several months and trades at less than half of the October highs.

So those are certainly possibilities, and you’ll have to make your guess as to which one might fit Mampilly’s criteria best… but for my part, my guess is that he’s teasing a truly beaten down stock, Namaste Technologies (N.V, NXTTF).

Don’t buy this stock because I’m guessing that, by the way. I don’t particularly like to write about teasers when I don’t have at least 99% certainty that I’m right, so I want to be clear that this is not an answer… it’s a guess. The Green Organic Dutchman or Curaleaf might easily be better matches (or better stocks, though I’m not buying any of the stocks I’m mentioning here), this is mostly just a hunch.

Why? Because there is real company-specific pessimism washing over this stock, and because Namaste pitches itself very specifically as trying to dominate one specific part of medical marijuana: matching the right patients with the right strains, using their telemedicine app and their database of available products (and delivery methods).

It might all be hooey, of course, the company has been dreadfully managed and recently fired its CEO because of the crazy promises he made at completely inappropriate company events, but that’s the claim they’re making.

Namaste really started out, and mostly still exists, as an online vendor of vape pens and associated products. They have been pitched a few times as the “Amazon of Weed” (a comparison they covet, of course), and they have basically started or acquired websites that sell vaping products in a bunch of different countries.

Their acquisition of Cannmart, which has now received the first “sales only” license from Health Canada, gives them the license to sell cannabis from different Canadian and international suppliers (and to grow it, though they say growing is not their intent), and the hope is that they’ll be able to sell a large variety of different strains from around the world and use use their artificial intelligence platform to best match consumers/patients to strains…. also leveraging the large customer base from their existing vape-product ecommerce operation, and integrating their NamasteMD “patient consultation” portal that can provide the telemedicine connection.

And, to be clear, I’m not buying the stock and wouldn’t recommend it to anyone — it’s just that it is the stock that’s a relatively close match, is not really trading with the pot sector overall, and might be close to some interpretation of “maximum pessimism” now that they’ve fired the CEO and initiated a “strategic review” that could even end up with the company being sold. The company issued a letter to shareholders that was full of optimism about their future on Friday, but it’s obviously a tumultuous time for the firm and I have no idea how it will end up. And, of course, the last few months of upheaval mean the company is quite distracted by lawsuits, both from shareholders and from their former CEO.

Namaste does not have any real analyst coverage, but it did report C$18.5 million in revenue in their fiscal year ending in August… which us US$14.5 million. I have not seen a public forecast of $600 million in revenue for Namaste for 2020 (or any other year), so that helps to reinforce that this is a guess.

The marijuana stocks are mostly down today, I assume that’s because we’re heading into the first real reporting period that will make any financial sense for the big Canadian marijuana operators — Canopy Growth (CGC), Aurora Cannabis (ACB) and Tilray (TLRY) should all be announcing their first quarters since Canada’s recreational legalization this week, so we’re going to begin to learn a little bit about what pricing has been like, how demand was in the first few weeks (they’re mostly reporting quarters that ended in November, not December, so data will be limited), and how these large producers are doing… with, perhaps, some guidance about how they see the market shaping up this year.

So sentiment about those results is likely to drive the whole marijuana stock market for this week… and yes, that might include results from Namaste, which would normally be on schedule to report earnings right around now, too, but has not announced a date. This isn’t the first time that Namaste has graced these pages, by the way — it was pitched as Tom Gardner’s favorite marijuana stock back in October, just as Citron’s short report drew attention to some of the unsavory stuff going on (though that recommendation might not have lasted long — as of January, Namaste was still disclosed as a Motley Fool recommendation, but last week when they posted a story about the CEO’s departure it was no longer listed in those footnotes).

And with that, I’ll leave you to your own guessing — have another company that you think is about to revolutionize medical marijuana, or that could match Mampilly’s (very limited) clues? Let us know with a comment below.


Irregulars Quick Take Paid members get a quick summary of the stocks teased and our thoughts here. Join as a Stock Gumshoe Irregular today (already a member? Log in)

156
Share your thoughts...

avatar
56 Comment threads
100 Thread replies
0 Followers
 
Most reacted comment
Hottest comment thread
99 Comment authors
amdeist1scubastevenjustifydrlb22steveflick Recent comment authors

This site uses Akismet to reduce spam. Learn how your comment data is processed.

dortelli
Member
πŸ‘31
dortelli

My favorite is Organigram. OGRMF, last quarter revenue equaled the entire previous year and they’re profitable.

Add a Topic
6418
frenchfry
Member
πŸ‘3
frenchfry

I agree with OGRMF because it is right around $5. In a “Market Talk” email he send to Profits Unlimited subscribers today he teased a pot stock under $5 that he would be announcing tomorrow for 10 Million Portfolio subscribers. The only thing is he also indicated it has a “disruptification” (his new buzzword) factor. Maybe he’s alluding to: “The core reason is that OrganiGram’s “unique three-tiered growing system has allowed it to become one of the most efficient growers — if not the most efficient — in all of Canada. At peak production capacity, for instance, OrganiGram should end… Read more Β»

Add a Topic
6418
Add a Topic
5274
Add a Topic
5893
heretik
Member
πŸ‘64
heretik

it’s Aurora. i’m a member of the Inner circle

capsix
Member
πŸ‘19
capsix

But Paul wouldn’t be about to issue a trade alert on ACB, correct?

Add a Topic
6237
dbc320
Member
πŸ‘14
dbc320

Do you currently own ACB? I’m considering a small limit order. Appears very volatile.

Add a Topic
6237
danielj1960
Member
πŸ‘62

I just bought 2650 shares a few weeks back with my hobby TD ameritrade account. I am going just let it ride. I am not a pot smoker,but my wife is a cancer survivor that has a lot of nerve and muscular pain from her mastectomy and chemo. MMJ and CBD products have made her more comfortable than anything else to include opioids !

Add a Topic
2740
Add a Topic
3397
jflynch
Guest
jflynch

I think the CBD is part of our future…because people steer away from the really addictive pain killers and see CBD with some THC as an alternative for pain.

fngwave
Member
πŸ‘13
fngwave

CBD helps my wife also. Thanks for sharing

jflynch
Guest
jflynch

I own ACB….down about $2 per share….looking at long term…not worried about it…also own 2 more companies of MJ….kind of stagnant lately….slow because startup time…I think.

richsumday
Member
πŸ‘7
richsumday

Nice try

capsix
Member
πŸ‘19
capsix

How old is this tease?

linz77
Member
πŸ‘3
linz77

What about Auscann ACNNF?

Add a Topic
6527
realtor24
Member
πŸ‘13
realtor24

I own some ACNNF too, but this is one that calls for a lot of patience. They look to be well positioned for the market in Australia at least. They have a very credible story and the management looks strong. I have lost some money on this, but not going to sell unless something drastic happens. Take a look at their website and see what you think.

Add a Topic
6527
Add a Topic
1270
portpals
Guest
portpals

I reviewed that Namaste, and read about all the inducing parties they were using to get business. After CGC, and Aurora, I did by a little Aleaf, OGRMF EMHTF,MMNTF,PLNHF and TGODF….these are relatively cheap and I hope I covered my bases….john (Houston)

Add a Topic
5087
Add a Topic
6361
Add a Topic
6418
Jeff
Guest

Check out HEMP. Very cheap,but looks good Long to me.

Add a Topic
4232
realtor24
Member
πŸ‘13
realtor24

If it is Aurora, I am long on them, held for over 2 years. Also have Canopy, Organigram, Charlotte’s Web, Kushco and GW Pharma. May take another look at Namaste, had it for a while and sold it.

Steve
Guest
Steve

You’re all over it.

Walter P
Guest
Walter P

Casey just had a flash sell alert on Kushco. They think it’s run its course.

Add a Topic
753
steveflick
Irregular
πŸ‘664

I thought MedMen MMNFF with the “pessimism” part, with 2 recent lawsuits one from investors, and most recent from former CFO; but their revenues ~21.5M last reported quarter is a disqualifier. I also thought as you did maybe Curaleaf CURLF or HarvestHealth HTHHF, and perhaps TruLieve TCNNF – but like you say they don’t have the ‘maximum pessimism’ factor and they all have higher $$revenues. the Thinkolator has come up with a very good guess! Mampilly nor Namaste – not for me!

Add a Topic
4091
Add a Topic
6393
Derby Dude
Guest
Derby Dude

Today is a great day to buy Aurora. The price is down and they report earnings tonight. Best estimate is that they will do good with earnings and the stock will take off tomorrow.

inve5tor
Member
πŸ‘11
inve5tor

Looks like Aurora missed on earnings but beat on revenue. They’re down about ten to fifteen cents after hours.

Add a Topic
5979
Derby Dude
Guest
Derby Dude

Give it a week or so for analysts to understand how good the financials were.

Rob
Member
πŸ‘3
Rob

Interesting name Dude. I was born in Derby
(pronounced Darby)

Derby Dude
Guest
Derby Dude

Unfortunately, I am not from Derby. Got the nickname from partying 16 years in a row in the infield at the Kentucky Derby

scubasteven
Member
πŸ‘27

Pclo- just started out. I can’t remember the site that had a small earnings number. Could that be it? Anyway you can send me an email address and I’ll send you the original investment pitch. It’s pretty impressive. If I would have had $10k to get involved with it I would have. I like that the board has ties to Big tobacco. Year round outside grows cuts the overhead down drastically because it takes alot of electricity to run those grow lights. I’ll send anyone a copy if they want it.

Add a Topic
501
scubasteven
Member
πŸ‘27

Also what is the best way to trade on the TSXV? Interactive brokers is the only one I’ve really found. For the US anyways

dgeysel
Irregular
πŸ‘2
dgeysel

Plus send me a copy. I missed the IPO; but looking to get in. Plus send to dgeysel@sympatico. Thx

Add a Topic
636
dee
Guest
dee

Send me a copy of the IPO as well.

Add a Topic
636
carlos
Guest
carlos

Please send a copy to i.premier@yahoo.com

Thanks

hittman
Member
πŸ‘56
hittman

i”ll take a copy. a.hitt@hotmail.com

jennierae
Member
πŸ‘4
jennierae

Love to have it. Jennierae.mcguire@gmail.com. Many thanks.

Paul Delude
Guest

Send me a copy at deludepa@aol.com thanks.

Bill
Guest
Bill

please send a copy to wllmdsy@aol,com

Mike Gumz
Guest
Mike Gumz

Please add me to the list also.
Magumz@centurylink.net

old mum
Member
πŸ‘0
old mum

Would you please e-mail me a copy of the report to tbryanbuilder@yahoo.com
Thank You

billyrob
Member
πŸ‘54
billyrob

Scubasteven.
I would appreciate a copy. Thank you.
I use Schwab and have about 50 stocks now and another 40 or so that I have sold, all thru Schwab. Almost all of them are Canadian company’s. Miners, pot, tech, bio, etc. $4.95 a trade, all done on my tablet. And I’m 80 yrs old. Easy.
billyrob0304@gmail.com

Rufus Everette
Guest
Rufus Everette

Please send me a copy…..ftajeep@hotmail.com…..Thanks

envision157
Member
πŸ‘0
envision157

Please send me a copy at envision157@yahoo.com . Thanks

Fred
Guest
Fred

Pls add my name to receive your generous offer.
Fataylor 1@comcast.net
Thanks

Gloris
Guest
Gloris

I would like a copy, thank you! gmfrendt@msn.com

big tuna
Member
πŸ‘96

Me too please:
mauisbigtuna@gmail.com

motordoc
Member
πŸ‘-39
motordoc

Please send copy also : angelomotordoc@hotmail.com